An Early Phase Study to Investigate the Safety and Efficacy of HS135 in Adult Patients With Pulmonary Arterial Hypertension (PAH)
Phase 1
Completed
- Conditions
- Pulmonary arterial hypertension
- Registration Number
- 2023-510452-23-00
- Lead Sponsor
- 35Pharma Inc., 35Pharma Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ended
- Sex
- Not specified
- Target Recruitment
- 16
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Not specified
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (5)
Universitätsmedizin Greifswald
🇩🇪Greifswald, Germany
Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR
🇩🇪Dresden, Germany
Medizinische Hochschule Hannover
🇩🇪Hanover, Germany
Krakowski Szpital Specjalistyczny Im. Sw. Jana Pawla II
🇵🇱Cracow, Poland
Semmelweis University
🇭🇺Budapest VIII, Hungary
Universitätsmedizin Greifswald🇩🇪Greifswald, GermanyRalf EwertSite contact004938348680596ralf.ewert@med.uni-greifswald.de